US Stock MarketDetailed Quotes

VCNX Vaccinex

Watchlist

0.761
+0.011+1.47%

15min DelayTrading Mar 31 14:06 ET

2.04MMarket Cap0.10P/E (TTM)

Vaccinex Stock Forum

Teddy123

Mar 8 23:05

Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market

$Vaccinex (VCNX.US)$
Can Vaccinex Survive After Nasdaq Exit? Key Details on Company's Future Strategy

🟢Watchlist Wednesday, December 4. NFA. Check on my previous watchlist. Those without ✅ means they can have delayed market reaction.

Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...

Jaguar8

Dec 3, 2024 08:05

🔴WATCHLIST Tuesday 12/3. NFA. Don’t open position without momentum. Use charts+indicators+order book. NO FOMO.

Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...

Trytosaveabit

Dec 3, 2024 05:00

News

$Vaccinex (VCNX.US)$ Vaccinex Has Been Granted Australian Patent Number 2018237549 Titled "Treatment Of Cancer With A Semaphorin-4d Antibody In Combination With An Epigenetic Modulating Agent"
Benzinga· just

Jaguar8

Nov 7, 2024 21:31

NEWS

$Vaccinex (VCNX.US)$
Vaccinex Provides Update on Activmab® Platform: Multiple Project Deals and Presentation at SITC
Vaccinex (NASDAQ: VCNX) announced multiple proprietary project agreements with major pharmaceutical companies including Amgen, Merck, Chugai, and others for using its ActivMAb® technology platform. The technology enables expression of complex proteins for antibody discovery, particularly useful for developing immunotherapies. The company will also provide materials to strategic...

Jaguar8

Nov 5, 2024 21:31

NEWS

$Vaccinex (VCNX.US)$
Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

Yuzuru0

Nov 1, 2024 06:20

$Vaccinex (VCNX.US)$ why bleeding so bad tho

Jaguar8

Nov 1, 2024 01:53

NEWS

$Vaccinex (VCNX.US)$
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain
Vaccinex (VCNX) announced new findings from its SIGNAL-AD Phase 1b/2 trial of pepinemab antibody in Alzheimer's disease. The study revealed that pepinemab treatment inhibits the expression of plasma GFAP and p-tau 217 biomarkers during Mild Cognitive Impairment (MCI). The treatment showed promising trends in slowing cogni...